Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Pharma Rejects Proposed Changes To Orphan Medicine Criteria

Companies Want More Incentives For New Drug Development

Executive Summary

The European Commission’s latest consultation on overhauling the EU legislation on medicines for children and for rare diseases has drawn some sharp responses from stakeholders.

You may also be interested in...



Swedish EU Presidency Promises Action On Pharma Law Revision, EMA Fees & AMR

Health care and medicines are among the priorities outlined by the new presidency of the Council of the EU for the first half of 2023.

US Industry Hauls Post-Brexit UK Over The Coals

PhRMA wants the UK to be placed on the US Trade Representative’s “Watch List” over issues such as the supplementary protection certificate waiver and delays in access to new drugs caused by “overlapping” cost-containment measures.

EU Seeks Suggestions On How To Improve Pediatric & Orphan Drugs Legislation

Companies wanting to get involved in long-running plans to overhaul the EU orphan drugs and pediatric medicine legislation can make their contribution through a public consultation that began on 10 May.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS144748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel